je.st
news
Insurers scrutinize drug costs after $84,000 Sovaldi surprise
2014-05-29 02:40:22| Biotech - Topix.net
Shocked by the rapid adoption of a new US$84,000 hepatitis C treatment, U.S. health insurers are trying to make sure they aren't blindsided by other drugs being developed and are looking for ways to limit their use from the day they are launched.
Tags: costs
drug
surprise
insurers
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||